https://www.milestone-advisorsllc.com/blog/in-the-news%3A-milestone-advisors-featured-in-fierce-biotech-on-pharma-m%26a-and-the-march-ipo-pause 2026-04-17 https://www.milestone-advisorsllc.com/blog/the-dual-track-is-working-for-biotech-companies-at-every-stage 2026-04-17 https://www.milestone-advisorsllc.com/blog/m%26a-is-dominating-investor-attention.-here's-what-public-biotechs-should-do.- 2026-04-13 https://www.milestone-advisorsllc.com/blog/clinical-data-communications%3A-what-biotech-teams-need-to-get-right 2026-04-03 https://www.milestone-advisorsllc.com/blog/the-case-for-dual-path-communications-in-life-sciences 2026-03-27 https://www.milestone-advisorsllc.com/blog/navigating-a-biotech-commercial-launch%3A-ir-and-communications-strategies-for-commercial-stage-companies 2026-03-13 https://www.milestone-advisorsllc.com/blog/how-life-sciences-companies-should-refresh-their-investor-deck-before-conference-season 2026-03-13 https://www.milestone-advisorsllc.com/blog/in-the-news%3A-milestone-advisors-featured-in-fierce-biotech-on-the-return-of-biotech-ipos 2026-03-04 https://www.milestone-advisorsllc.com/blog/biotech-optimism-is-returning.-now-is-the-time-to-engage-new-investors 2026-02-11 https://www.milestone-advisorsllc.com/blog/is-your-biotech-actually-ready-for-an-ipo 2026-03-04 https://www.milestone-advisorsllc.com/blog/getting-more-from-your-biotech-ir-calendar-2026 2026-01-23 https://www.milestone-advisorsllc.com/blog/jpm-2026%3A-what-biotech-ir-advisors-are-hearing-and-what-it-means-for-the-year-ahead 2026-01-15 https://www.milestone-advisorsllc.com/blog/how-to-discuss-life-science-competitors-without-losing-credibility 2025-12-12 https://www.milestone-advisorsllc.com/blog/communicating-bad-news-in-biotech- 2025-12-05 https://www.milestone-advisorsllc.com/blog/the-generalists-are-back- 2025-12-05 https://www.milestone-advisorsllc.com/blog/what-biotech-leaders-should-know-about-sell-side-engagement 2025-12-12 https://www.milestone-advisorsllc.com/blog/optimizing-your-ir-calendar 2025-12-12 https://www.milestone-advisorsllc.com/blog/it%E2%80%99s-time-to-refresh-your-corporate-deck 2025-11-07 https://www.milestone-advisorsllc.com/blog/getting-the-most-out-of-shorter-biotech-investor-meetings 2025-10-31 https://www.milestone-advisorsllc.com/blog/preparing-your-s-1%3A-what-life-sciences-companies-should-do-as-the-ipo-window-begins-to-open 2026-03-04 https://www.milestone-advisorsllc.com/blog/biotech-investor-relations%3A-green-shoots%2C-higher-bar 2025-12-11 https://www.milestone-advisorsllc.com/blog/the-rules-have-changed 2025-10-30